NeueHealth, Inc.
NEUE · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $2 |
| Revenue | $1 | $1 | $1 | $2 |
| % Growth | -19.3% | 54.5% | -50.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 20.8% | 14.1% | 11.7% | 14.5% |
| EBITDA | -$0 | -$1 | -$0 | -$0 |
| % Margin | -7% | -48.8% | -42.4% | -20.4% |
| Net Income | -$0 | -$1 | -$1 | -$1 |
| % Margin | -14.4% | -99.2% | -193.8% | -78.3% |
| EPS Diluted | -22.65 | -150.94 | -190.04 | -150.77 |
| % Growth | 85% | 20.6% | -26% | – |
| Operating Cash Flow | -$0 | -$3 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$3 | $0 | $0 |